Medication info
Janualecto 100/30 mg (Sitagliptin Phosphate, Pioglitazone Hydrochloride)

Janualecto 100/30 mg (Sitagliptin Phosphate, Pioglitazone Hydrochloride)

Prescription medicationTablet
Ingredient · strength
Sitagliptin Phosphate Hydrate›128.5mg / 1 tabletPioglitazone Hydrochloride›33.06mg / 1 tablet
Manufacturer / importer
Jinyang Pharmaceutical Co., Ltd.
Appearance
Light orange rectangular film-coated tablets
Packaging
28 tablets/box [14 tablets/PTP x 2]
Approval status
Active

MFDS item code 202302299 · Approved 2023.07.31 · Insurance code 650304540

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
This medicine may be administered as 1 tablet once daily, regardless of meals, to patients with type 2 diabetes mellitus receiving concomitant sitagliptin 100mg and pioglitazone 15mg or 30mg. Assessment of renal function is recommended before starting this medicine and periodically during treatment. -If the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or higher, no dosage adjustment based on renal function is necessary. -Do not administer this medicine if the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73m2.

Ingredients

Manufacturer
Jinyang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to enhance blood sugar control in patients with type 2 diabetes in conjunction with diet and exercise. It is particularly suitable for patients using sitagliptin and pioglitazone together and helps effectively manage blood sugar levels.

Dosage and Administration

Adult dosage

This medicine may be administered as 1 tablet once daily, regardless of meals, to patients with type 2 diabetes mellitus receiving concomitant sitagliptin 100mg and pioglitazone 15mg or 30mg. Assessment of renal function is recommended before starting this medicine and periodically during treatment. -If the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or higher, no dosage adjustment based on renal function is necessary. -Do not administer this medicine if the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73m2.

Precautions

This medicine contains sitagliptin and pioglitazone and is used for the treatment of type 2 diabetes. The sitagliptin component can rarely cause serious allergic reactions, so if skin rashes, difficulty breathing, or swelling of the face or neck occur after taking the medication, discontinue use immediately and consult a physician. Additionally, pancreatitis (inflammation of the pancreas) can occur, so if symptoms like abdominal pain, vomiting, or nausea arise, seek medical attention promptly. The pioglitazone component may put stress on the heart; therefore, patients with a history of heart failure or heart disease should not take this medication. Patients at risk for heart failure should closely monitor for symptoms such as weight gain, shortness of breath, and ankle swelling, and consult a physician if any symptoms occur. This medication may be affected by kidney function, so patients with impaired renal function should consult a physician before use, and regular kidney function tests are recommended. Also, this medication should not be used in patients with a history of bladder cancer or active bladder cancer, and if any bladder-related symptoms (hematuria, dysuria, etc.) occur, inform a doctor immediately. Women who are pregnant or may become pregnant should avoid taking this medication, and premenopausal women may need to use effective contraception during treatment, as there is an increased possibility of pregnancy. While taking this medication, hypoglycemic symptoms (dizziness, cold sweat, severe fatigue, etc.) may occur, so caution is advised, especially when used in combination with other diabetes medications, as the risk of hypoglycemia may increase. Various side effects such as swelling, weight gain, headache, upper respiratory infection, etc., may occur during treatment; consult a physician if symptoms arise. Finally, this medication can interact with other drugs, so if you are taking any other medications, be sure to inform your doctor or pharmacist and seek their advice.

Side effects

  • Hypersensitivity reactions
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • congestive heart failure
  • fluid retention
  • edema
  • hypoglycemia
  • upper respiratory tract infection
Show 80 more
  • nasopharyngitis
  • headache
  • diarrhea
  • abdominal pain
  • nausea
  • constipation
  • vomiting
  • severe joint pain with disability
  • bullous pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • elevated blood glucose
  • increased ALT
  • increased AST
  • decreased appetite
  • upper abdominal pain
  • chest pain
  • fatigue
  • weakness
  • dyspnea
  • itching
  • chest discomfort
  • tremor
  • chills
  • gastrointestinal disease
  • epigastric discomfort
  • numbness
  • muscle rigidity
  • head discomfort
  • increased liver enzymes
  • worsening of liver disease
  • urticaria
  • eczema
  • joint pain
  • knee abnormalities
  • arm weakness syndrome
  • proteinuria
  • increased serum creatinine
  • anxiety
  • insomnia
  • drowsiness
  • simple herpes
  • blurred vision
  • hypertension
  • heart failure
  • orthostatic hypotension
  • palpitations
  • stroke
  • sexual dysfunction
  • myocardial infarction
  • weight gain
  • urinary tract infection
  • low back pain
  • dizziness
  • abdominal distension
  • elevated serum creatine kinase
  • sinusitis
  • heart failure
  • limb pain
  • thoracic pain
  • cardiovascular adverse events
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • liver failure
  • decreased vision
  • diabetic macular edema
  • hepatotoxicity
  • fracture

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a container that is opaque to light. Additionally, avoid damp environments and store at a cool temperature between 15 and 30 degrees Celsius. This will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Light orange rectangular film-coated tablets

Package unit

28 tablets/box [14 tablets/PTP x 2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.